Newron Pharmaceuticals S.p.A. announced that Bo Jesper Hansen has informed the Board of Directors of his intention to step down as a Non-Executive Director, effective from this year’s Annual Shareholders Assembly taking place on March 27, 2018. Bo is member of the Company's Audit & Risk Committee and Chairman of the Research and Development Committee. Non-Executive Director Don deBethizy will take over as Chairman of the Research and Development Committee.